Harris Emilio Foster Jr MD
Professor of Urology; Director, Female Urology and Neuro-Urology; Residency Program Director
- Practice Locations: York Street Campus, VA Connecticut Healthcare System (West Haven, Newington), and Gaylord Hopsital
- Residency - University of Michigan
- Clinical Interests: Female urology, urodynamics, neurogenic bladder, male and female urinary incontinence, interstitial cystitis; voiding dysfunction; benign prostatic hyperplasia, erectile dysfunction, urologic cancers.
Dr. Harris E. Foster Jr. is board certified in urology and has specialized interests in voiding dysfunction and female urology. Particular to this area include treatment of female and male urinary incontinence, neurgogenic bladder, benign prostatic hyperplasia (PBH), interstitial cystitis, urethral diverticula and vesicovaginal fisulae. In addition, Dr. Foster treats general urological conditions such as kidney stones, erectile dysfunction, prostate cancer, superficial bladder cancer, and benign conditions involving the scrotum (hydrocele, epididymal cyst). He also performs circumcision and vasectomy in patients who desire these procedures. Dr. Foster has expertise in the evaluation of voiding dysfunction utilizing urodynamics.
Dr. Foster earned his undergraduate degree from the University of Michigan at Ann Arbor. He then graduated with honors from University of Miami School of Medicine, a member of the Alpha Omega Alpha medical honor society. Dr. Foster subsequently completed his urology residency at the University of Michigan Hospitals and joined the faculty at Yale University School of Medicine. Dr. Foster is Chief of Urology for the Veteran’s Administration Connecticut Healthcare System and is a urology consultant at the Gaylord Rehabilitation Hospital in Wallingford, Connecticut and The Hospital for Special Care in New Britain, Connecticut. He also provides urological care at the Yale University Health Services. Dr. Foster has received grants from the National Institutes of Health (NIH) to perform clinical trials investigating the pharmacologic and phytotherapeutic treatment of BPH. He was also the chairman for many years of the NIH sponsored Interstitial Cystitis Collaborative Research Network. Dr. Foster was a member of the American Board of Urology Examination Committee and has functioned as an oral board examiner for this organization. He has written numerous research publications and textbook chapters and is a reviewer for many of the major urology journals including The Journal of Urology, Urology, and Neurourology and Urodynamics. Finally, Dr. Foster has been a member of the guidelines committee for the evaluation and treatment of BPH and overactive bladder (OAB) sponsored by the American Urological Association.
Dr. Foster is dedicated to treating patients suffering from urological diseases with a particular focus on those who have voiding dysfunction. He recognizes that although most of these disorders do not affect duration of life, they can in many instances have significant if not devastating effects on quality of life. Despite being a urological surgeon, he fully understands that surgery is not frequently indicated nor is it always the best option for many patients.
Education & Training
- University of Miami (1987)
- University of Michigan, Ann Arbor, MI, General Surgery (1987 - 1989)
- University of Michigan, Ann Arbor, MI, Urology (1989 - 1992)
- Board Certification
- Urology, Board Certified (1994)